These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3743888

  • 21. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
    Bouhoute A, Leclercq G.
    Biochem Biophys Res Commun; 1992 May 15; 184(3):1432-40. PubMed ID: 1590802
    [Abstract] [Full Text] [Related]

  • 22. Effects of sulfhydryl reagents on uterine nuclear estrogen receptors labeled by in vitro exchange with [3H]estradiol or [3H]4-hydroxytamoxifen.
    Attardi B.
    J Recept Res; 1984 May 15; 4(7):787-800. PubMed ID: 6527361
    [Abstract] [Full Text] [Related]

  • 23. Analysis of the 4-hydroxytamoxifen (4-OHTAM) bound nuclear estrogen receptor from MCF-7 cells by limited proteolysis.
    Geier A, Beery R, Haimsohn M, Lunenfeld B.
    J Steroid Biochem; 1987 Nov 15; 28(5):471-8. PubMed ID: 3682814
    [Abstract] [Full Text] [Related]

  • 24. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
    Borgna JL, Scali J.
    Eur J Biochem; 1991 Aug 01; 199(3):575-85. PubMed ID: 1868844
    [Abstract] [Full Text] [Related]

  • 25. Identification of immunoassayable estrogen receptor lacking hormone binding ability in tamoxifen-treated rat uterus.
    Nakao M, Sato B, Koga M, Noma K, Kishimoto S, Matsumoto K.
    Biochem Biophys Res Commun; 1985 Oct 15; 132(1):336-42. PubMed ID: 3904747
    [Abstract] [Full Text] [Related]

  • 26. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies.
    Giambiagi N, Pasqualini JR.
    J Steroid Biochem; 1988 Oct 15; 30(1-6):213-7. PubMed ID: 3386244
    [Abstract] [Full Text] [Related]

  • 27. Antiestrogen binding sites in rat liver nuclei.
    Kon OL.
    Biochim Biophys Acta; 1985 Dec 13; 843(3):245-53. PubMed ID: 4063396
    [Abstract] [Full Text] [Related]

  • 28. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 13; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

  • 29. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
    Monsma FJ, Katzenellenbogen BS, Miller MA, Ziegler YS, Katzenellenbogen JA.
    Endocrinology; 1984 Jul 13; 115(1):143-53. PubMed ID: 6734512
    [Abstract] [Full Text] [Related]

  • 30. Estradiol receptor of calf uterus: interactions with heparin-agarose and purification.
    Molinari AM, Medici N, Moncharmont B, Puca GA.
    Proc Natl Acad Sci U S A; 1977 Nov 13; 74(11):4886-90. PubMed ID: 270721
    [Abstract] [Full Text] [Related]

  • 31. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
    Pavlik EJ, van Nagell JR, Nelson K, Gallion H, Donaldson ES, Kenady DE, Baranowska-Kortylewicz J.
    Endocrinology; 1986 May 13; 118(5):1924-34. PubMed ID: 2422013
    [Abstract] [Full Text] [Related]

  • 32. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW, Mangel WF.
    Cancer Res; 1984 Jan 13; 44(1):112-9. PubMed ID: 6537799
    [Abstract] [Full Text] [Related]

  • 33. Differential interaction of antiestrogens with cytosol estrogen receptors.
    Black LJ, Jones CD, Goode RL.
    Mol Cell Endocrinol; 1981 Apr 13; 22(1):95-103. PubMed ID: 7239000
    [Abstract] [Full Text] [Related]

  • 34. Purification and characterization of mouse uterine estrogen receptor under conditions of varying hormonal status.
    Horigome T, Golding TS, Quarmby VE, Lubahn DB, McCarty K, Korach KS.
    Endocrinology; 1987 Dec 13; 121(6):2099-111. PubMed ID: 3678140
    [Abstract] [Full Text] [Related]

  • 35. Nuclear [3H]4-hydroxytamoxifen (4-OHTAM)- and [3H]estradiol (E2)-estrogen receptor complexes in the MCF-7 breast cancer and GH3 pituitary tumor cell lines.
    Tate AC, Jordan VC.
    Mol Cell Endocrinol; 1984 Jul 13; 36(3):211-9. PubMed ID: 6468749
    [Abstract] [Full Text] [Related]

  • 36. Antiestrogen modulation of the salt-resistant nuclear estrogen receptor.
    Ruh TS, Baudendistel LJ.
    Endocrinology; 1978 Jun 13; 102(6):1838-46. PubMed ID: 744052
    [No Abstract] [Full Text] [Related]

  • 37. Characterization of an antiidiotypic antibody mimicking the actions of estradiol and its interaction with estrogen receptors.
    Mor G, Amir-Zaltsman Y, Barnard G, Kohen F.
    Endocrinology; 1992 Jun 13; 130(6):3633-40. PubMed ID: 1597160
    [Abstract] [Full Text] [Related]

  • 38. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS, Baudendistel LJ.
    Endocrinology; 1977 Feb 13; 100(2):420-6. PubMed ID: 832632
    [Abstract] [Full Text] [Related]

  • 39. Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: evidence for an endogenous ligand.
    Murphy PR, Butts C, Lazier CB.
    Endocrinology; 1984 Jul 13; 115(1):420-6. PubMed ID: 6734522
    [Abstract] [Full Text] [Related]

  • 40. [Characterization of the "4 S-trypsin" form of the cytosoluble estradiol receptor of calf uterus in a nondenaturing system].
    Secco-Millet C, Soulignac O, Rocher P, Baulieu EE, Richard-Foy H.
    C R Acad Hebd Seances Acad Sci D; 1977 Jan 10; 284(2):137-40. PubMed ID: 402239
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.